GRASP age at death with kuru exposure, beta-thalassemia/hemoglobin e disease (absolute fetal hemoglobin (hb), g/dl), beta-thalassemia/hemoglobin e disease (fetal hemoglobin (hb), %), beta-thalassemia/hemoglobin e disease (severity), decrease in fev1 (in nonasthmatic participants >=30 years old), microalbuminuria, tetrology of fallot